Kynurenine Pathway in Autism Spectrum Disorders in Children

Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer

(2018) Francisco S. Barreto et al.   BEHAVIOURAL PHARMACOLOGY

Cytokine Profile in Autism Spectrum Disorders in Children

(2016) Vesna Bryn et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity

(2015) Chai K. Lim et al.   Autism Research

Evidence supporting an altered immune response in ASD

(2015) Jennifer Mead et al.   IMMUNOLOGY LETTERS

Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition

(2014) Katerina Zavitsanou et al.   BRAIN BEHAVIOR AND IMMUNITY

Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala

(2014) George Anderson et al.   Current Neuropharmacology

Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis

(2014) Stefano Gabriele et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis

(2014) A Masi et al.   MOLECULAR PSYCHIATRY

Immunological and autoimmune considerations of Autism Spectrum Disorders

(2013) Benjamin Gesundheit et al.   JOURNAL OF AUTOIMMUNITY

Connecting inflammation with glutamate agonism in suicidality

(2013) Sophie Erhardt et al.   NEUROPSYCHOPHARMACOLOGY

Observed prevalence of autism spectrum disorders in two Norwegian counties

(2012) Jørn Isaksen et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Children with autism spectrum disorders – The importance of medical investigations

(2012) Jørn Isaksen et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Kynurenines in the mammalian brain: when physiology meets pathology

(2012) Robert Schwarcz et al.   NATURE REVIEWS NEUROSCIENCE

Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway

(2012) Michael Maes et al.   PSYCHIATRY RESEARCH

Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder

(2011) M. Elizabeth Sublette et al.   BRAIN BEHAVIOR AND IMMUNITY

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?

(2011) Johann Steiner et al.   Journal of Neuroinflammation

The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression

(2010) M. Maes et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Autism

(2009) Susan E Levy et al.   LANCET

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression

(2009) C L Raison et al.   MOLECULAR PSYCHIATRY

The Role of Epilepsy and Epileptiform EEGs in Autism Spectrum Disorders

(2009) Sarah J Spence et al.   PEDIATRIC RESEARCH

Epidemiology of Pervasive Developmental Disorders

(2009) Eric Fombonne   PEDIATRIC RESEARCH